SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today ...

EO2002 is a first-in-class, non-surgical cell therapy with the ability to modify disease via Emmecell's exclusive Magnetic Cell Delivery (MCD) nanotechnology platform. EO2002 offers the promise of a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. AURN001 is an allogeneic cell therapy being evaluated ...

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has ...

Please provide your email address to receive an email when new articles are posted on . A 79-year-old woman was referred to the Cornea Service for progressive corneal edema and decreased vision in the ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc.

An EndoArt artificial corneal graft was implanted for the first time in a patient suffering from severe corneal edema, after he rejected 3 biological grafts from donors.

Researchers at Harvard Medical School have demonstrated the potent therapeutic effects of administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) through melanocortin receptor ...

Medically reviewed by Andrew Greenberg, MD Allergies, dry eye, corneal injury, infection, and tiredness are common causes of ...

Five cases are presented to emphasize the fact that chronic use of topical anesthetics on the eye can lead to severe keratitis and even permanent reduction of visual acuity. These reactions can be ...